Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3 - PubMed (original) (raw)

Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3

E N Hatada et al. EMBO J. 1993 Jul.

Abstract

The vertebrate NF-kappa B/c-rel inhibitors MAD-3/I kappa B alpha, I kappa B gamma/pdI and bcl-3 all share a conserved ankyrin repeat domain (ARD) consisting of six complete repeats, a short acidic motif and/or an incomplete seventh repeat. We present here a detailed analysis of the domain in p105/pdI and MAD-3/I kappa B involved in inhibition of DNA binding and in protein interaction with rel factors. We demonstrate that in both cases an acidic region and six ankyrin-like repeats are sufficient and required for protein interaction with the rel factors. However, for p105/pdI to achieve the high affinity needed to suppress DNA binding, an incomplete seventh repeat is required in addition. Both pdI and MAD-3 associate with rel proteins by forming heterotrimeric complexes, as shown by native gel analysis and by cross-linking. Furthermore, we demonstrate that deletion of only three amino acids in the first repeat converts the subunit specificity of the p105 ARD into that of MAD-3/I kappa B. We conclude that functionally the ARD in these molecules has a modular structure, with different subregions determining the specificity for the NF-kappa B subunits p50 and p65.

PubMed Disclaimer

Similar articles

• Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
  Matthews JR, Watson E, Buckley S, Hay RT. Matthews JR, et al. Nucleic Acids Res. 1993 Sep 25;21(19):4516-23. doi: 10.1093/nar/21.19.4516. Nucleic Acids Res. 1993. PMID: 7694229 Free PMC article.
• The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
  Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C. Hatada EN, et al. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2489-93. doi: 10.1073/pnas.89.6.2489. Proc Natl Acad Sci U S A. 1992. PMID: 1532257 Free PMC article.
• The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
  Gerondakis S, Morrice N, Richardson IB, Wettenhall R, Fecondo J, Grumont RJ. Gerondakis S, et al. Cell Growth Differ. 1993 Aug;4(8):617-27. Cell Growth Differ. 1993. PMID: 8398903
• The inhibitory ankyrin and activator Rel proteins.
  Nolan GP, Baltimore D. Nolan GP, et al. Curr Opin Genet Dev. 1992 Apr;2(2):211-20. doi: 10.1016/s0959-437x(05)80276-x. Curr Opin Genet Dev. 1992. PMID: 1386268 Review.
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
  Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Verma IM, et al. Genes Dev. 1995 Nov 15;9(22):2723-35. doi: 10.1101/gad.9.22.2723. Genes Dev. 1995. PMID: 7590248 Review. No abstract available.

Cited by

• IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.
  Schouten GJ, Vertegaal AC, Whiteside ST, Israël A, Toebes M, Dorsman JC, van der Eb AJ, Zantema A. Schouten GJ, et al. EMBO J. 1997 Jun 2;16(11):3133-44. doi: 10.1093/emboj/16.11.3133. EMBO J. 1997. PMID: 9214631 Free PMC article.
• Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
  Van Antwerp DJ, Verma IM. Van Antwerp DJ, et al. Mol Cell Biol. 1996 Nov;16(11):6037-45. doi: 10.1128/MCB.16.11.6037. Mol Cell Biol. 1996. PMID: 8887633 Free PMC article.
• Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation.
  Sun S, Elwood J, Greene WC. Sun S, et al. Mol Cell Biol. 1996 Mar;16(3):1058-65. doi: 10.1128/MCB.16.3.1058. Mol Cell Biol. 1996. PMID: 8622650 Free PMC article.
• Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.
  Hirano F, Chung M, Tanaka H, Maruyama N, Makino I, Moore DD, Scheidereit C. Hirano F, et al. Mol Cell Biol. 1998 May;18(5):2596-607. doi: 10.1128/MCB.18.5.2596. Mol Cell Biol. 1998. PMID: 9566879 Free PMC article.
• Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
  Miyamoto S, Chiao PJ, Verma IM. Miyamoto S, et al. Mol Cell Biol. 1994 May;14(5):3276-82. doi: 10.1128/mcb.14.5.3276-3282.1994. Mol Cell Biol. 1994. PMID: 8164680 Free PMC article.

References

1. 1. DNA Cell Biol. 1992 Sep;11(7):523-37 - PubMed
2. 1. Int Rev Cytol. 1993;143:1-62 - PubMed
3. 1. Arch Biochem Biophys. 1968 Jul;126(1):155-64 - PubMed
4. 1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
5. 1. Anal Biochem. 1980 Nov 15;109(1):76-86 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program